About Intus Bio
Intus Bio is a company based in Farmington (United States) founded in 2014.. Intus Bio has raised $4.14 million across 5 funding rounds from investors including HHS. Intus Bio has completed 1 acquisition, including Pattern Genomics. Intus Bio offers products and services including Titan-1™ Platform and GutID. Intus Bio operates in a competitive market with competitors including Inflammatix, Visby Medical, MeMed, Pendulum and GenMark Diagnostics, among others.
- Headquarter Farmington, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Intus Biosciences, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.14 M (USD)
in 5 rounds
-
Latest Funding Round
$1.09 M (USD), Seed
May 15, 2025
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intus Bio
Intus Bio offers a comprehensive portfolio of products and services, including Titan-1™ Platform and GutID. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-powered system for high-resolution microbiome data and strain tracking.
Home-based test for personal gut microbiome analysis and insights.
Unlock access to complete
R Team
1 people
Leadership Team
1 people
Co Team
1 people
Software Development Team
1 people
Microbiome Team
1 people
Unlock access to complete
Funding Insights of Intus Bio
Intus Bio has successfully raised a total of $4.14M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1.09 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $1.1M
-
First Round
First Round
(01 May 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Seed - Intus Bio | Valuation |
investors |
|
| Jun, 2024 | Amount | Series A - Intus Bio | Valuation |
investors |
|
| Jun, 2024 | Amount | Debt – Conventional - Intus Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Intus Bio
Intus Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Intus Bio
Intus Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pattern Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Large-scale bioinformatics sequence analysis is applied for molecular assay design.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Intus Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intus Bio Comparisons
Competitors of Intus Bio
Intus Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Visby Medical, MeMed, Pendulum and GenMark Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intus Bio
Frequently Asked Questions about Intus Bio
When was Intus Bio founded?
Intus Bio was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is Intus Bio located?
Intus Bio is headquartered in Farmington, United States.
Who is the current CEO of Intus Bio?
Ken Beers is the current CEO of Intus Bio.
Is Intus Bio a funded company?
Intus Bio is a funded company, having raised a total of $4.14M across 5 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on May 01, 2017.
What does Intus Bio do?
Intus Bio was founded in 2014 in Farmington, United States, within the biotechnology sector. Sequencing technology is provided for microbiome testing, pathogen identification, and tracking. A platform named Titan-1 is utilized, employing a patented 16S-ITS-23S amplicon to distinguish bacterial strains without requiring full genome sequencing. Operations focus on enabling efficient microbial analysis for research and diagnostic applications.
Who are the top competitors of Intus Bio?
Intus Bio's top competitors include Visby Medical, Tessera Therapeutics and Inflammatix.
What products or services does Intus Bio offer?
Intus Bio offers Titan-1™ Platform and GutID.
How many acquisitions has Intus Bio made?
Intus Bio has made 1 acquisition, including Pattern Genomics.
Who are Intus Bio's investors?
Intus Bio has 1 investor. Key investors include HHS.